20-45515556-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000217428.7(SPINT3):āc.53A>Cā(p.Glu18Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000187 in 1,550,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000217428.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPINT3 | NM_006652.2 | c.53A>C | p.Glu18Ala | missense_variant | 1/2 | ENST00000217428.7 | NP_006643.1 | |
LOC107987282 | XR_001754641.3 | n.100-17718T>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPINT3 | ENST00000217428.7 | c.53A>C | p.Glu18Ala | missense_variant | 1/2 | 1 | NM_006652.2 | ENSP00000217428 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 151084Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000257 AC: 4AN: 155776Hom.: 0 AF XY: 0.0000242 AC XY: 2AN XY: 82548
GnomAD4 exome AF: 0.0000186 AC: 26AN: 1399026Hom.: 0 Cov.: 32 AF XY: 0.0000203 AC XY: 14AN XY: 690006
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151204Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73836
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2023 | The c.53A>C (p.E18A) alteration is located in exon 1 (coding exon 1) of the SPINT3 gene. This alteration results from a A to C substitution at nucleotide position 53, causing the glutamic acid (E) at amino acid position 18 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at